Report Detail
COVID-19 Impact on Global Biosimilars, Market Insights and Forecast to 2026
- RnM4075520 |
- 24 June, 2020 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Biosimilars market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Biosimilars market is segmented into
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Peptides (Glucagon, Calcitonin)
Segment by Application, the Biosimilars market is segmented into
Oncology
Blood Disorders
Regional and Country-level Analysis
The Biosimilars market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biosimilars market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biosimilars Market Share Analysis
Biosimilars market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilars business, the date to enter into the Biosimilars market, Biosimilars product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Novartis
Teva Pharmaceuticals Industries
Amgen
Biocon
Dr. Reddy’s Laboratories
Roche Holding
Celltrion
Samsung BioLogics
1 Study Coverage
- 1.1 Biosimilars Product Introduction
- 1.2 Market Segments
- 1.3 Key Biosimilars Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Biosimilars Market Size Growth Rate by Type
- 1.4.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
- 1.4.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
- 1.4.4 Peptides (Glucagon, Calcitonin)
- 1.5 Market by Application
- 1.5.1 Global Biosimilars Market Size Growth Rate by Application
- 1.5.2 Oncology
- 1.5.3 Blood Disorders
- 1.6 Coronavirus Disease 2019 (Covid-19): Biosimilars Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Biosimilars Industry
- 1.6.1.1 Biosimilars Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Biosimilars Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Biosimilars Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Biosimilars Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Biosimilars Market Size Estimates and Forecasts
- 2.1.1 Global Biosimilars Revenue 2015-2026
- 2.1.2 Global Biosimilars Sales 2015-2026
- 2.2 Biosimilars Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Biosimilars Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Biosimilars Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Biosimilars Competitor Landscape by Players
- 3.1 Biosimilars Sales by Manufacturers
- 3.1.1 Biosimilars Sales by Manufacturers (2015-2020)
- 3.1.2 Biosimilars Sales Market Share by Manufacturers (2015-2020)
- 3.2 Biosimilars Revenue by Manufacturers
- 3.2.1 Biosimilars Revenue by Manufacturers (2015-2020)
- 3.2.2 Biosimilars Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Biosimilars Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Biosimilars Revenue in 2019
- 3.2.5 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Biosimilars Price by Manufacturers
- 3.4 Biosimilars Manufacturing Base Distribution, Product Types
- 3.4.1 Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Biosimilars Product Type
- 3.4.3 Date of International Manufacturers Enter into Biosimilars Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Biosimilars Market Size by Type (2015-2020)
- 4.1.1 Global Biosimilars Sales by Type (2015-2020)
- 4.1.2 Global Biosimilars Revenue by Type (2015-2020)
- 4.1.3 Biosimilars Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Biosimilars Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Biosimilars Sales Forecast by Type (2021-2026)
- 4.2.2 Global Biosimilars Revenue Forecast by Type (2021-2026)
- 4.2.3 Biosimilars Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Biosimilars Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Biosimilars Market Size by Application (2015-2020)
- 5.1.1 Global Biosimilars Sales by Application (2015-2020)
- 5.1.2 Global Biosimilars Revenue by Application (2015-2020)
- 5.1.3 Biosimilars Price by Application (2015-2020)
- 5.2 Biosimilars Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Biosimilars Sales Forecast by Application (2021-2026)
- 5.2.2 Global Biosimilars Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Biosimilars Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Biosimilars by Country
- 6.1.1 North America Biosimilars Sales by Country
- 6.1.2 North America Biosimilars Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Biosimilars Market Facts & Figures by Type
- 6.3 North America Biosimilars Market Facts & Figures by Application
7 Europe
- 7.1 Europe Biosimilars by Country
- 7.1.1 Europe Biosimilars Sales by Country
- 7.1.2 Europe Biosimilars Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Biosimilars Market Facts & Figures by Type
- 7.3 Europe Biosimilars Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Biosimilars by Region
- 8.1.1 Asia Pacific Biosimilars Sales by Region
- 8.1.2 Asia Pacific Biosimilars Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Biosimilars Market Facts & Figures by Type
- 8.3 Asia Pacific Biosimilars Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Biosimilars by Country
- 9.1.1 Latin America Biosimilars Sales by Country
- 9.1.2 Latin America Biosimilars Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Biosimilars Market Facts & Figures by Type
- 9.3 Central & South America Biosimilars Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Biosimilars by Country
- 10.1.1 Middle East and Africa Biosimilars Sales by Country
- 10.1.2 Middle East and Africa Biosimilars Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Biosimilars Market Facts & Figures by Type
- 10.3 Middle East and Africa Biosimilars Market Facts & Figures by Application
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description, Business Overview and Total Revenue
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer Biosimilars Products Offered
- 11.1.5 Pfizer Recent Development
- 11.2 Novartis
- 11.2.1 Novartis Corporation Information
- 11.2.2 Novartis Description, Business Overview and Total Revenue
- 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Novartis Biosimilars Products Offered
- 11.2.5 Novartis Recent Development
- 11.3 Teva Pharmaceuticals Industries
- 11.3.1 Teva Pharmaceuticals Industries Corporation Information
- 11.3.2 Teva Pharmaceuticals Industries Description, Business Overview and Total Revenue
- 11.3.3 Teva Pharmaceuticals Industries Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Teva Pharmaceuticals Industries Biosimilars Products Offered
- 11.3.5 Teva Pharmaceuticals Industries Recent Development
- 11.4 Amgen
- 11.4.1 Amgen Corporation Information
- 11.4.2 Amgen Description, Business Overview and Total Revenue
- 11.4.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Amgen Biosimilars Products Offered
- 11.4.5 Amgen Recent Development
- 11.5 Biocon
- 11.5.1 Biocon Corporation Information
- 11.5.2 Biocon Description, Business Overview and Total Revenue
- 11.5.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Biocon Biosimilars Products Offered
- 11.5.5 Biocon Recent Development
- 11.6 Dr. Reddy’s Laboratories
- 11.6.1 Dr. Reddy’s Laboratories Corporation Information
- 11.6.2 Dr. Reddy’s Laboratories Description, Business Overview and Total Revenue
- 11.6.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Dr. Reddy’s Laboratories Biosimilars Products Offered
- 11.6.5 Dr. Reddy’s Laboratories Recent Development
- 11.7 Roche Holding
- 11.7.1 Roche Holding Corporation Information
- 11.7.2 Roche Holding Description, Business Overview and Total Revenue
- 11.7.3 Roche Holding Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Roche Holding Biosimilars Products Offered
- 11.7.5 Roche Holding Recent Development
- 11.8 Celltrion
- 11.8.1 Celltrion Corporation Information
- 11.8.2 Celltrion Description, Business Overview and Total Revenue
- 11.8.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Celltrion Biosimilars Products Offered
- 11.8.5 Celltrion Recent Development
- 11.9 Samsung BioLogics
- 11.9.1 Samsung BioLogics Corporation Information
- 11.9.2 Samsung BioLogics Description, Business Overview and Total Revenue
- 11.9.3 Samsung BioLogics Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Samsung BioLogics Biosimilars Products Offered
- 11.9.5 Samsung BioLogics Recent Development
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description, Business Overview and Total Revenue
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer Biosimilars Products Offered
- 11.1.5 Pfizer Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Biosimilars Market Estimates and Projections by Region
- 12.1.1 Global Biosimilars Sales Forecast by Regions 2021-2026
- 12.1.2 Global Biosimilars Revenue Forecast by Regions 2021-2026
- 12.2 North America Biosimilars Market Size Forecast (2021-2026)
- 12.2.1 North America: Biosimilars Sales Forecast (2021-2026)
- 12.2.2 North America: Biosimilars Revenue Forecast (2021-2026)
- 12.2.3 North America: Biosimilars Market Size Forecast by Country (2021-2026)
- 12.3 Europe Biosimilars Market Size Forecast (2021-2026)
- 12.3.1 Europe: Biosimilars Sales Forecast (2021-2026)
- 12.3.2 Europe: Biosimilars Revenue Forecast (2021-2026)
- 12.3.3 Europe: Biosimilars Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Biosimilars Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Biosimilars Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Biosimilars Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Biosimilars Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Biosimilars Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Biosimilars Sales Forecast (2021-2026)
- 12.5.2 Latin America: Biosimilars Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Biosimilars Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Biosimilars Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Biosimilars Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Biosimilars Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Biosimilars Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Biosimilars Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Biosimilars Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Biosimilars. Industry analysis & Market Report on COVID-19 Impact on Global Biosimilars is a syndicated market report, published as COVID-19 Impact on Global Biosimilars, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
